VMP 36129511000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Oxycodone 10mg modified-release tablets
BNF code 0407020ADAAAFAF
Virtual Therapeutic Moiety Oxycodone
Date identifier became valid 5 Nov 2018
Previous product identifier 322694004
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Caution - AMP level prescribing advised
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Oxycodone hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 10.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletmodified-release.oral
Dose Form
Formulation Modified-release tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category Schedule 2 (CD)
Actual Medicinal Products
Ixyldone 10mg modified-release tablets (Morningside Healthcare Ltd)
Longtec 10mg modified-release tablets (CST Pharma Ltd)
Longtec 10mg modified-release tablets (Qdem Pharmaceuticals Ltd)
Oxeltra 10mg modified-release tablets (Wockhardt UK Ltd)
OxyContin 10mg modified-release tablets (Lexon (UK) Ltd)
OxyContin 10mg modified-release tablets (Napp Pharmaceuticals Ltd)
Oxylan 10mg prolonged-release tablets (G.L. Pharma UK Ltd)
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd)
Reltebon 10mg modified-release tablets (Accord-UK Ltd)
Reltebon 10mg modified-release tablets (CST Pharma Ltd)
Virtual Medicinal Product Packs
Oxycodone 10mg modified-release tablets 14 tablet
Oxycodone 10mg modified-release tablets 28 tablet
Oxycodone 10mg modified-release tablets 56 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.

Feedback